Dan Chicoine is now the interim Chief Executive Officer of Crescita Therapeutics Inc., a commercial dermatology company in Canada.

He is replacing Greg Orleski.  Mr. Chicoine will also continue to serve as the Company's Executive Chairman.

Crescita has a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms.  In addition, the company owns multiple proprietary drug delivery platforms that support the development of patented formulations to facilitate transdermal delivery. Crescita recently acquired INTEGA Skin Sciences Inc. (INTEGA), a Montreal-based dermatology company.